• Policy & Insight

Cancer Research UK responds to the Governments new Childhood Obesity Plan

Cancer Research UK responds to the Governments new Childhood Obesity Strategy. Cancer Research UK responds to the Governments new Childhood Obesity Strategy.

25 June 2018

• Health & Medicine

Number of elderly diagnosed with cancer set to rocket by 80% in less than 20 years

The number of older people diagnosed with cancer every year could rise by up to 80% to nearly a quarter of a million by 2035, according to new figures. The number of older people diagnosed with cancer every year could rise by up to 80% to nearly a quarter of a million by 2035, according to new figures.

21 June 2018

• Health & Medicine

Drug could protect children from hearing loss after chemo

New trials results show that a drug can reduce hearing loss in children treated with the chemo drug cisplatin. New trials results show that a drug can reduce hearing loss in children treated with the chemo drug cisplatin.

20 June 2018

• Health & Medicine

New drug halves hearing loss in children following cancer treatment

Giving the drug sodium thiosulphate after chemotherapy reduces hearing loss in children treated for liver cancer, according to new research. Giving the drug sodium thiosulphate after chemotherapy reduces hearing loss in children treated for liver cancer, according to new research.

20 June 2018

• Health & Medicine

Cancer Research UK tests first of its kind vaccine to treat lung cancer

A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer. A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer.

12 June 2018

• Health & Medicine

Prostate cancer drug given initial ‘no’ for NHS in England

The prostate cancer drug abiraterone has been provisionally rejected as a first-line treatment on the NHS in England. The prostate cancer drug abiraterone has been provisionally rejected as a first-line treatment on the NHS in England.

7 June 2018

• Health & Medicine

Older breast cancer patients in England less likely to survive than in four other European countries

Older women diagnosed with breast cancer in England are less likely to survive their disease than those in Belgium, Poland, Ireland and the Netherlands. Older women diagnosed with breast cancer in England are less likely to survive their disease than those in Belgium, Poland, Ireland and the Netherlands.

7 June 2018

• Health & Medicine

Lung cancer immunotherapy drug approved for England

The lung cancer immunotherapy drug pembrolizumab has been made widely available on the NHS in England after a price deal was reached. The lung cancer immunotherapy drug pembrolizumab has been made widely available on the NHS in England after a price deal was reached.

6 June 2018

• Health & Medicine

Combining heartburn drugs and aspirin could help prevent oesophageal cancer in people at high risk

Two over-the-counter, widely available drugs could help cut cases of oesophageal cancer in people at higher risk of the disease. Two over-the-counter, widely available drugs could help cut cases of oesophageal cancer in people at higher risk of the disease.

4 June 2018

• Health & Medicine

Chemo combo could help pancreatic cancer patients live longer after surgery

A combination of chemotherapy drugs was better than a single drug at extending the lives of pancreatic cancer patients after surgery. A combination of chemotherapy drugs was better than a single drug at extending the lives of pancreatic cancer patients after surgery.

4 June 2018

• Health & Medicine

Chemoradiotherapy before surgery may extend lives of pancreatic cancer patients

Pancreatic cancer patients treated with chemotherapy and radiotherapy before surgery may live longer than those who have immediate surgery. Pancreatic cancer patients treated with chemotherapy and radiotherapy before surgery may live longer than those who have immediate surgery.

4 June 2018

• Health & Medicine

Taking aspirin and anti-acid reflux medication prevents oesophageal cancer in high risk patients

Taking an anti-acid reflux medication together with a low dose of aspirin can prevent oesophageal cancer in people with a high risk of the disease. Taking an anti-acid reflux medication together with a low dose of aspirin can prevent oesophageal cancer in people with a high risk of the disease.

4 June 2018